Target intelligence / Profile preview

Gamma-aminobutyric acid type A receptor alpha1beta2gamma2S subtype (GABA_A receptor alpha1beta2gamma2S)

Target
GABA_A receptor alpha1beta2gamma2S
Molecular classification
Ion channel, Ligand-gated ion channel, Receptor, Cys-loop receptor
01

Overview

The Gamma-aminobutyric acid type A receptor alpha1beta2gamma2S subtype is a pentameric ligand-gated ion channel that serves as the primary mediator of fast inhibitory neurotransmission in the mammalian central nervous system [1, 2]. It is composed of two alpha-1, two beta-2, and one gamma-2S (short splice variant) subunits arranged around a central chloride-selective pore [2, 7]. Activation by the endogenous neurotransmitter GABA leads to chloride influx, resulting in membrane hyperpolarization and a subsequent decrease in neuronal firing [1, 6]. This specific receptor configuration is the most abundant GABA_A receptor subtype in the brain and is the principal target for benzodiazepines, which bind at the alpha/gamma subunit interface to enhance GABA-mediated currents [2, 4]. The alpha-1 subunit within this complex is specifically linked to the sedative, hypnotic, and anticonvulsant properties of GABAergic drugs, while the gamma-2S subunit is crucial for receptor clustering at synapses and benzodiazepine sensitivity [4, 6]. Clinically, this receptor is targeted to treat conditions such as insomnia, anxiety, and epilepsy, though its modulation is also associated with side effects like sedation, ataxia, and the potential for physical dependence [6].

Other names
GABAA receptor alpha1beta2gamma2Salpha1beta2gamma2S GABA(A) receptorBZ1 receptorBenzodiazepine receptor type 1GABRA1-GABRB2-GABRG2S complex
02

Mechanism of action

Positive allosteric modulation of the GABA-induced chloride current

03

Biological functions

Inhibitory synaptic transmissionChloride ion transportPostsynaptic membrane hyperpolarizationRegulation of neuronal excitabilitySignal transduction
04

Disease associations

EpilepsyInsomniaAnxiety disorderAlcohol use disorderNeurodevelopmental disorder
05

Safety considerations

SedationAtaxiaCognitive impairmentPhysical dependenceWithdrawal syndromeRespiratory depression
06

Interacting drugs

Diazepam

7 more in the full profile.

07

Biomarkers

[11C]flumazenil (PET ligand)Electroencephalogram (EEG) beta-band power oscillations

Beyond the preview

Go deeper on Gamma-aminobutyric acid type A receptor alpha1beta2gamma2S subtype (GABA_A receptor alpha1beta2gamma2S).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-aminobutyric acid type A receptor alpha1beta2gamma2S subtype (GABA_A receptor alpha1beta2gamma2S).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call